These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10914877)

  • 1. Nabumetone induced pseudoporphyria in childhood.
    Cron RQ; Finkel TH
    J Rheumatol; 2000 Jul; 27(7):1817-8. PubMed ID: 10914877
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoporphyria induced by nabumetone.
    Krischer J; Scolari F; Kondo-Oestreicher M; Vollenweider-Roten S; Saurat JH; Pechère M
    J Am Acad Dermatol; 1999 Mar; 40(3):492-3. PubMed ID: 10071328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabumetone-associated pseudoporphyria.
    Antony F; Layton AM
    Br J Dermatol; 2000 May; 142(5):1067-9. PubMed ID: 10809892
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudoporphyria caused by nabumetone.
    Varma S; Lanigan SW
    Br J Dermatol; 1998 Mar; 138(3):549-50. PubMed ID: 9580823
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs.
    Meggitt SJ; Farr PM
    Br J Dermatol; 1999 Sep; 141(3):591-2. PubMed ID: 10583088
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudoporphyria associated with Relafen therapy.
    Magro CM; Crowson AN
    J Cutan Pathol; 1999 Jan; 26(1):42-7. PubMed ID: 10189244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of nabumetone induced pseudoporphyria.
    Checketts SR; Morgan GJ
    J Rheumatol; 1999 Dec; 26(12):2703-5. PubMed ID: 10606389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaprozin-induced pseudoporphyria.
    Ingrish G; Rietschel RL
    Arch Dermatol; 1996 Dec; 132(12):1519-20. PubMed ID: 8961891
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nabumetone is an alternative].
    Melander A
    Lakartidningen; 2003 Apr; 100(17):1547. PubMed ID: 12756699
    [No Abstract]   [Full Text] [Related]  

  • 10. Diclofenac-induced pseudoporphyria; an under-recognized condition?
    Turnbull N; Callan M; Staughton RC
    Clin Exp Dermatol; 2014 Apr; 39(3):348-50. PubMed ID: 24635077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis.
    Goodman S; Howard P; Haig A; Flavin S; Macdonald B
    J Rheumatol; 2003 Apr; 30(4):829-31. PubMed ID: 12672207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoporphyria induced by propionic acid derivatives.
    Al-Khenaizan S; Schechter JF; Sasseville D
    J Cutan Med Surg; 1999 Jan; 3(3):162-6. PubMed ID: 10082597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.
    Stroehmann I; Giersch KH; Zeidler H; Münzel P
    Drugs; 1990; 40 Suppl 5():50-2. PubMed ID: 2081493
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudoporphyria from nonsteroidal antiinflammatory drugs.
    Taylor BJ; Duffill MB
    N Z Med J; 1987 May; 100(824):322-3. PubMed ID: 3451093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Naproxen-induced pseudoporphyria].
    Maerker JM; Harm A; Foeldvari I; Höger PH
    Hautarzt; 2001 Nov; 52(11):1026-9. PubMed ID: 11757457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 1: Naproxen-induced pseudoporphyria.
    O'Donoghue NB; Higgins EM
    Clin Exp Dermatol; 2002 Jun; 27(4):339-40. PubMed ID: 12139696
    [No Abstract]   [Full Text] [Related]  

  • 17. Photosensitizing potential of certain nonsteroidal anti-inflammatory agents.
    Kaidbey KH; Mitchell FN
    Arch Dermatol; 1989 Jun; 125(6):783-6. PubMed ID: 2730099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary fibrosis associated with nabumetone.
    Morice A; Atherton A; Gleeson F; Stewart S
    Postgrad Med J; 1991 Nov; 67(793):1021-2. PubMed ID: 1775411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac.
    Melarange R; Gentry C; Blower PR; Toseland CD; Spangler R
    Eur J Rheumatol Inflamm; 1994; 14(2):15-22. PubMed ID: 7744129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous photosensitivity to naproxen: "pseudoporphyria".
    Suarez SM; Cohen PR; DeLeo VA
    Arthritis Rheum; 1990 Jun; 33(6):903-8. PubMed ID: 2194465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.